Synowledge, a market leader known for its global and progressive approach to providing drug safety, regulatory affairs and related IT solutions to life sciences organizations, is pleased to announce its participation in the National Multiple Sclerosis (MS) Walk 2013, to be held on Sunday, April 28th, 2013 in New York City.
As Synowledge continues to expand its global footprint in the life sciences industry, the company pledges to support the National MS Society to create a world free of Multiple Sclerosis. The Synowledge team participating in the walk will include several US employees as well as family and friends who are supporting the cause. Synowledge aims to raise $5,000 for this cause and looks forwarding to participating in the walk on April 28th. Interested participants who would like to join the Synowledge team can contact Sindhoori Nalla (Sindhoori.firstname.lastname@example.org) for team registration information.
Synowledge is a premier provider of drug safety, regulatory affairs and enterprise level IT Services to small, mid and large sized companies. Our range of services enables pharmaceutical, biotech, medical devices and health care organizations to meet their drug safety and regulatory affairs requirements while supporting their enterprise management systems. Our proficiency in sustaining, optimizing and enhancing ERP implementations, Business Intelligence enablement and Content Management Systems empowers Life Sciences, Manufacturing, Industrial Products organizations to achieve business and operational excellence. Our comprehensive solutions combines the strengths of our on-shore and offshore capabilities to meet our client’s requirements while they channel their focus on their core competencies. Synowledge is headquartered in Stamford, CT, USA with operational facilities in 7 locations across Europe, North America and India. For more information, please visit www.synowledge.com.